Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRHI Magnesita Regulatory News (RHIM)

Share Price Information for RHI Magnesita (RHIM)

Share Price is delayed by 15 minutes
Get Live Data
2,730.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 95.00 (3.525%)
Market Cap: £1.29b
RHIM Live PriceLast checked at - London Stock Exchange

Intraday RHI Magnesita Share Chart

Trading Update

10 Nov 2025 07:00

RNS Number : 8392G
RHI Magnesita N.V.
10 November 2025
 

10th November 2025

RHI Magnesita N.V.

("RHI Magnesita" or "the Group")

 

TRADING UPDATE

Delivering in a challenging backdrop

 

RHI Magnesita, the leading global supplier of high-quality refractory products, systems and solutions, today provides an update on trading for the ten months ended 31 October 2025 (the "Period"). Given the strong second-half weighting of earnings, this update covers the four months from July to October 2025.

 

Trading

 

The Group delivered the expected improvement in performance over the four months from July to October, in line with full-year guidance.

 

Adjusted EBITA for the four months was €136 million, representing a 12.7% margin, significantly ahead of the run-rate in H1 2025 (six months ended 30 June 2025 of €141 million, 8.4% margin), despite the third quarter typically being a seasonally weaker period due to northern hemisphere summer breaks.

 

Steel volumes for the period remained weak and broadly consistent with full-year guidance, reflecting subdued but stable overall demand, with only modest improvement compared to the first half. Demand for high-quality steel for the automotive sector was particularly soft in western markets. The Group saw growth in the Period in India, META (Middle East, Africa and Türkiye), with European demand contracting further. Market share in India was re-established during the Period, as expected.

 

The Industrial project order book has improved throughout the last months, in line with guidance provided at the H1 2025 results, with clear visibility for the remainder of 2025. High-margin industrial projects are however still at a low point, with order volumes around 40% below recent years. The concentration of industrial order delivery in H2 is caused by seasonality and customers shifting orders.

 

The pricing environment remains highly competitive, particularly in markets with overcapacity, such as China, and in regions heavily supplied by Chinese exports, including India, East Asia and the Middle East.  Small price increases were nevertheless achieved as our customers continue to value our local-for-local supply, the value-creating 4PRO contracts and innovation pipeline.

 

The Group's cost efficiency programmes remain solidly on track, with expected SG&A reductions and fixed cost savings from two plant closures in Germany in line with previous full-year guidance. These measures account for the vast majority of the margin improvement in the Period.

 

Earnings growth from the former Resco plants is progressing well, with integration advancing smoothly and synergies being delivered in line with expectations. The integration is enabling the Group to generate enhanced benefits from its North American footprint. US local-for-local production has increased from 50% to 65% in 2025 and is expected to exceed 75% in H2 2026. While increased US local production has mitigated the Group's overall tariff exposure, more recent headwinds have emerged with tariffs on raw materials and finished goods exported from Brazil to the US.

 

Backward integration margins remain near historical lows, at 1.1% year-to-date, as a result of very low raw material pricing across most categories. Further action around cost reduction and portfolio optimisation are being implemented in the raw materials plants and mines to improve earnings from backward integration stepwise over the next two years.

 

Financial Position

Working capital increased temporarily in the Period, to support delivery of the stronger Q4 order book. The booked project deliveries in the remainder of the year, together with the seasonal peak sales in the cement industry, will enable the Group to de-lever during Q4 to approximately 3.0x by year-end.

 

Outlook

 

The Group remains on track to deliver the full-year Adjusted EBITA of €370-390 million, supported by market share recovery in India and META, executed management initiatives in cost reduction and the seasonal recovery expected in China. The weak US Dollar and Indian Rupee continue to weigh on reported financial performance.

 

The current industrial order book, in particular, underpins expectations that the improved performance achieved in H2 2025 will continue into H1 2026, with the modest pricing benefits retained. Nevertheless, end-markets demand especially in the steel industry remains at a cyclical low, and a rapid normalisation is not anticipated.

 

Global trade update:

· The European Commission proposes cutting by almost half its tariff-free steel import quota to support onshoring steel production volumes. While the exact timing in 2026 is still uncertain, resultant higher steel production in-region could stabilise refractory demand in Europe.

· Brazil has officially launched an investigation into potential duty protection for refractory materials. The outcome and timing is uncertain at this point.

With strong market positions in both regions and a well-invested local network, this could become a positive development for RHI Magnesita in late 2026 or 2027.

 

Stefan Borgas, Chief Executive Officer of RHI Magnesita, said:

 

"RHI Magnesita has delivered the expected step-up improvement through the second half of 2025 by systematically implementing its self-help actions. This is despite subdued demand conditions. The Group has successfully executed cost reduction initiatives in all cost categories, progressed plant closures, and captured synergies from the Resco acquisition. Market share in India has been re-established, and modest pricing discipline has supported results despite intense competition. I would like to thank the RHI Magnesita-team globally for this outstanding operational performance. Looking ahead, our self-help actions and innovation projects underpin confidence that the momentum from the second half of 2025 will carry into the first half of 2026."

 

Conference Call

A conference call will be hosted at 8:15am UK time to discuss the trading update:

Dial in

+44 20 3936 2999

+44 808 189 0158 (UK toll-free)

Access code

 488947

Webcast and playback facility

https://www.investis-live.com/rhimagnesita/68f9e645127f1e000e40ce22/ypkk

 

For further enquiries, please contact:

Alexander Ordosch, Head of Investor Relations

Tel +43 699 1870 6162

E‐mail: Alexander.Ordosch@rhimagnesita.com

 

Media:

Hudson Sandler

Tel +44 020 7796 4133

E-mail: rhimagnesita@hudsonsandler.com

 

About RHI Magnesita

RHI Magnesita is the leading global supplier of high-grade refractory products, systems and solutions which are critical for high-temperature processes exceeding 1,200°C in a wide range of industries, including steel, cement, non-ferrous metals and glass. With a vertically integrated value chain, from raw materials to refractory products and full performance-based solutions, RHI Magnesita serves customers around the world, with over 20,000 employees in 65 main production sites (including raw material sites), 12 recycling facilities and more than 70 sales offices. RHI Magnesita intends to leverage its leadership in terms of revenue, scale, product portfolio and diversified geographic presence to target strategically those countries and regions benefiting from more dynamic economic growth prospects.

RHI Magnesita offers investors EBITDA and free cash flow comparable to FTSE 100 peers, the highest free cash flow yield in the UK industrials sector, a compelling M&A growth story and high operational gearing to market recovery. The Group seeks to allocate capital to maximise value generation for shareholders. After maintenance capex and dividend, M&A, organic investments and buybacks compete for capital. The global refractory industry remains fragmented and the M&A pipeline presents an opportunity to continue a value-accretive consolidation strategy.

The Group is listed within the Equity Shares (Commercial Companies) category ("ESCC") of the Official List of the London Stock Exchange (symbol: RHIM) and is a constituent of the FTSE 250 index, with a secondary listing on the Vienna Stock Exchange (Wiener Börse). For more information please visit: www.rhimagnesita.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKCBBCBDDPDK
Date   Source Headline
1st Aug 20247:00 amRNSTotal Voting Rights
24th Jul 20247:00 amRNS2024 Half Year Results
12th Jul 20241:40 pmRNSNotice of Results
14th Jun 20247:00 amRNSNotification of major shareholding
6th Jun 20248:45 amRNSDirector/PDMR Shareholding
3rd Jun 20248:54 amRNSTotal Voting Rights
9th May 202412:11 pmRNSExercise of LTIP Options by PDMR
8th May 202410:03 amRNSDirector/PDMR Shareholding
3rd May 20244:12 pmRNSExercise of LTIP Options by PDMR
3rd May 20242:00 pmRNSDirector/PDMR Shareholding
2nd May 20243:56 pmRNSResult of AGM
2nd May 20247:00 amRNSQ1 2024 Trading Update
1st May 20249:27 amRNSTotal Voting Rights
2nd Apr 20241:16 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSAcquisition of Resco Group
21st Mar 20249:03 amRNSNotice of AGM
8th Mar 20249:29 amRNSDirector/PDMR Shareholding
28th Feb 202411:50 amRNS2023 Full Year Results
1st Feb 20247:46 amRNSTotal Voting Rights
31st Jan 20247:00 amRNSNotice of Results
2nd Jan 20247:00 amRNSTotal Voting Rights
1st Dec 20239:02 amRNSTotal Voting Rights
1st Dec 20238:39 amRNSNotification of major shareholding
31st Oct 20237:00 amRNSQ3 2023 Trading Update
16th Oct 20237:00 amRNSNotification of major shareholding
3rd Oct 20237:00 amRNSAcquisition of P-D Refractories
26th Sep 202311:00 amRNSDirector Nomination
1st Sep 20237:00 amRNSTotal Voting Rights
28th Jul 202310:55 amRNSNotification of major shareholding
27th Jul 20233:47 pmRNSNotification of major shareholding
26th Jul 20237:00 amRNSRHI Magnesita half-year results
19th Jul 20233:36 pmRNSNotice of Results
10th Jul 20235:31 pmRNSResponse to partial offer extension
3rd Jul 202311:48 amRNSTotal Voting Rights
27th Jun 20238:53 amRNSResponse to partial offer
19th Jun 20233:20 pmRNSNotification of major shareholding
16th Jun 20237:00 amRNSTotal Voting Rights
16th Jun 20237:00 amRNSReplacement: Exercise of LTIP Options by PDMRs
15th Jun 20237:00 amRNSTrading Update
31st May 20231:40 pmRNSExercise of LTIP Options by PDMRs
30th May 202311:04 amRNSResponse to intended partial cash offer
24th May 20234:10 pmRNSResult of AGM 2023
5th May 20237:00 amRNSQ1 2023 Trading Update
21st Apr 20234:11 pmRNSAcquisition of Seven Refractories
13th Apr 20237:00 amRNSDebt financing update
12th Apr 20237:00 amRNSRHI Magnesita - Notice of AGM 2023
5th Apr 20235:00 pmRNSIndian subsidiary equity issuance
29th Mar 20234:47 pmRNSIndian subsidiary equity issuance
29th Mar 20237:00 amRNSAcquisition of Dalmia GSB Refractories GmbH
6th Mar 20235:39 pmRNS2023 Long Term Incentive Plan Awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.